Stay updated on MT-5111 in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MT-5111 in HER2+ Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the Notice about government funding lapse and the prior Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T20:26:22.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding notice about data currency and updated the site revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:50:13.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI and metadata updates include showing the glossary toggle label, adding the 'Last Update Submitted that Met QC Criteria' field, and displaying 'Revision: v3.4.0' alongside the addition of 'No FEAR Act Data'. The core study details remain unchanged.
    Difference
    0.2%
    Check dated 2026-01-28T07:31:41.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No substantive study content appears to be altered.
    Difference
    0.0%
    Check dated 2026-01-14T03:26:11.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section listing study sites by state and country, expanding geographic coverage. The revision is updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T21:33:24.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. The page content and study details remain unchanged.
    Difference
    0.0%
    Check dated 2025-11-25T11:22:31.000Z thumbnail image

Stay in the know with updates to MT-5111 in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MT-5111 in HER2+ Solid Tumors Clinical Trial page.